Literature DB >> 28769424

PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN HOSPITALIZED POPULATION SUBSETS.

V C Ohri1, Mkk Rao2, K Banerjee3, D Raghunath4, K Kher5, R M Gupta2, S K Nema6, Lavan Singh7.   

Abstract

Prevalence of antibodies to hepatitis C virus (anti-HCV antibody) was ascertained in different subsets of hospitalized patients. Anti-HCV antibody testing was done using a third generation test The anti-HCV positivity in the sera of 308 tuberculosis patients, who had been given streptomycin, was 12.3 per cent It was 7.1 percent among 84 cardiac patients undergoing invasive cardiac procedures, 15.6 per cent in 77 patients on haemodialysis and 41.2 per cent patients with surgical jaundice. It is surmised that hospitalization, particularly parenteral therapy and invasive procedures during hospitalization, puts patients at higher risk of contracting HCV infecticn.

Entities:  

Keywords:  Hepatitis C Virus; Hospital infection; Hospitalization; Prevalence

Year:  2017        PMID: 28769424      PMCID: PMC5530779          DOI: 10.1016/S0377-1237(17)30634-2

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  12 in total

1.  Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.

Authors:  E Ponz; J M Campistol; J M Barrera; C Gil; J Pinto; J Andreu; M Bruguera
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Hepatitis C virus antibodies in haemodialysis patients.

Authors: 
Journal:  Lancet       Date:  1990-06-09       Impact factor: 79.321

3.  Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India.

Authors:  J Nandi; V Bhawalkar; H Mody; A Elavia; P K Desai; K Banerjee
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

4.  Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals.

Authors:  G Giusti; B Galanti; G B Gaeta; C Gallo
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

5.  Intrafamilial transmission of hepatitis C virus in Japan.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; S Shimizu; S Furuta; Y Miyazaki; Y Akahane; H Suzuki
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

6.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Hepatitis C virus infection in chronic liver disease in Bombay.

Authors:  D N Amarapurkar; A Kumar; S S Parikh; K B Chopra; P Murti; R H Kalro; H G Desai
Journal:  Indian J Gastroenterol       Date:  1992-10

8.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

Authors:  R D Aach; C E Stevens; F B Hollinger; J W Mosley; D A Peterson; P E Taylor; R G Johnson; L H Barbosa; G J Nemo
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

9.  Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden.

Authors:  L Mattsson; B Aberg; M von Sydow; O Weiland
Journal:  Scand J Infect Dis       Date:  1991

10.  Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.

Authors:  A M Lever; A D Webster; D Brown; H C Thomas
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

View more
  1 in total

1.  HEPATITIS C VIRUS: WHERE IS IT LEADING US?

Authors:  Abha K Sabhikhi; Ramji Rat
Journal:  Med J Armed Forces India       Date:  2017-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.